Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: Recommendations from a European nursing task group
Kim Edmonds, Diana Hull, Andrea Spencer-Shaw, José Koldenhof, Maria Chrysou, Christine Boers-Doets, Alexander MolassiotisVolume:
16
Year:
2012
Language:
english
Pages:
185
DOI:
10.1016/j.ejon.2011.05.001
File:
PDF, 520 KB
english, 2012